FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan
This article was originally published in The Gray Sheet
Executive Summary
FDA and the Centers for Medicare & Medicaid Services are likely to have a closer relationship under the tenure of incoming commissioner Mark McClellan, MD/PhD